High Cholesterol
References
Citations
Grundy SM, et al. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285(19): 2486–2497.
U.S. Preventive Services Task Force, Agency for Healthcare and Research (2003). Screening for Diabetes Mellitus, Adult Type 2. Available online: http://www.ahrq.gov/clinic/uspstf/uspsdiab.htm.
Nissen SE, et al. (2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. New England Journal of Medicine, 352(1): 29–38.
Ridker PM, et al. (2005). C-reactive protein levels and outcomes after statin therapy. New England Journal of Medicine, 352(1): 20–28.
Ridker RM, et al. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 107(3): 391–397.
Pearson TA, et al. (2003). Markers of inflammation and cardiovascular disease: American Heart Association and the Centers for Disease Control and Prevention scientific statement. Circulation, 107(3): 499–511.
Foster C, et al. (2004). Primary prevention. Clinical Evidence (11): 163–195.
Pignone M, et al. (2004). Secondary prevention of ischaemic cardiac events. Clinical Evidence (12): 193–235.
Grundy SM, et al. (2004). Implications of recent clinical trials of the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation, 110(2): 227–239. [Erratum in Circulation, 110(6): 763.]
Kraus WE, et al. (2002). Effects of the amount and intensity of exercise on plasma lipoproteins. New England Journal of Medicine, 347(19): 1483–1492.
Lichtenstein AH, Van Horn L (1998). Very low fat diets. Circulation, 98(9): 935–939.
Other Works Consulted
Brunzell JD, Failor RA (2005). Diagnosis and treatment of dyslipidemia. In DC Dale, DD Federman, eds., ACP Medicine, section 9, chap. 2. New York: WebMD.
Genest J, Libby P (2008). Lipoprotein disorders and cardiovascular disease. In P Libby et al., eds., Braunwald's Heart Disease, 8th ed., vol. 1, pp. 1071–1092. Philadelphia: Saunders Elsevier.
Kavey RW, et al. (2003). American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation, 107(11): 1562–1566.
Krummel DA (2008). Medical nutrition therapy for cardiovascular disease. In LK Mahan, S Escott-Stump, eds., Krause's Food and Nutrition Therapy, 12th ed., pp. 833–864. St. Louis: Saunders Elsevier.
Maron DJ, et al. (2004). Dyslipidemia, other risk factors, and the prevention of coronary heart disease. In V Fuster et al., eds., Hurst's The Heart, 11th ed., pp. 1093–1122. New York: McGraw-Hill.
Mosca L, et al. (2007). Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation, 115(11): 1481–1501.
Stone NJ, Blum CB (2004). Management of Lipids in Clinical Practice. Caddo, OK: Professional Communications.
 Go to previous section |  Go to top of page |  Go to next section |
| Author: | Robin Parks, MS | Last Updated: July 20, 2006 |
| Medical Review: | E. Gregory Thompson, MD - Internal Medicine Robert A. Kloner, MD, PhD - Cardiology | |
 | ||
